semaglutide/tirzepatide Semaglutide & Tirzepatide: Can You Combine Them? Addressing the Weight Loss Injectable

There is also growing clinical interest in semaglutide for women with PCOS-related obesity, where central weight gain is often resistant to diet and exercise alone

As no two persons have the same profile of hormonal system, a baseline test is ordered for by caregiving teams

Luger et al

I need you out there sharing this podcast, sharing what you learned from this podcast, rallying behind the movement and asking your doctors for better, and literally those little acts

For weight management, FDA labeling and Endocrine Society guidelines recommend evaluating whether patients achieve at least 5% weight loss after approximately 12 weeks on the maintenance dosea benchmark that requires accurate baseline and follow-up measurements